The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Saphenous Vein

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Saphenous Vein


High impact information on Saphenous Vein


Chemical compound and disease context of Saphenous Vein


Biological context of Saphenous Vein


Anatomical context of Saphenous Vein


Associations of Saphenous Vein with chemical compounds


Gene context of Saphenous Vein


Analytical, diagnostic and therapeutic context of Saphenous Vein


  1. Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. Etude de la Ticlopidine après Pontage Fémoro-Poplité and the Association Universitaire de Recherche en Chirurgie. Becquemin, J.P. N. Engl. J. Med. (1997) [Pubmed]
  2. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Hoff, H.F., Beck, G.J., Skibinski, C.I., Jürgens, G., O'Neil, J., Kramer, J., Lytle, B. Circulation (1988) [Pubmed]
  3. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. Solymoss, B.C., Nadeau, P., Millette, D., Campeau, L. Circulation (1988) [Pubmed]
  4. Recombinant endothelial nitric oxide synthase-transduced human saphenous veins: gene therapy to augment nitric oxide production in bypass conduits. Cable, D.G., O'Brien, T., Schaff, H.V., Pompili, V.J. Circulation (1997) [Pubmed]
  5. Elective operations for post-infarction left ventricular aneurysms. Sbokos, C.G., Monro, J.L., Ross, J.K. Thorax (1976) [Pubmed]
  6. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. Weksler, B.B., Pett, S.B., Alonso, D., Richter, R.C., Stelzer, P., Subramanian, V., Tack-Goldman, K., Gay, W.A. N. Engl. J. Med. (1983) [Pubmed]
  7. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. Beasley, D., McGuiggin, M. J. Exp. Med. (1994) [Pubmed]
  8. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. Hawrylowicz, C.M., Howells, G.L., Feldmann, M. J. Exp. Med. (1991) [Pubmed]
  9. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. Libby, P., Alroy, J., Pereira, M.E. J. Clin. Invest. (1986) [Pubmed]
  10. The dipeptide carnosine constricts rabbit saphenous vein as a zinc complex apparently via a serotonergic receptor. O'Dowd, A., O'Dowd, J.J., Miller, D.J. J. Physiol. (Lond.) (1996) [Pubmed]
  11. Growth inhibition of human vascular smooth muscle cells by fenofibrate: a possible therapy for restenosis. Munro, E., Patel, M., Chan, P., Betteridge, L., Gallagher, K., Schachter, M., Wolfe, J., Sever, P. Cardiovasc. Res. (1994) [Pubmed]
  12. Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice. Schepers, A., Pires, N.M., Eefting, D., de Vries, M.R., van Bockel, J.H., Quax, P.H. J. Vasc. Surg. (2006) [Pubmed]
  13. Carotid-subclavian bypass--a decade of experience. Perler, B.A., Williams, G.M. J. Vasc. Surg. (1990) [Pubmed]
  14. Atherogenic effect of barotrauma on in situ saphenous veins in monkeys. Boerboom, L.E., Olinger, G.N., Rodriguez, E.R., Ferrans, V.J., Kissebah, A.H. J. Thorac. Cardiovasc. Surg. (1991) [Pubmed]
  15. Differences in alpha-adrenergic responsiveness between human internal mammary arteries and saphenous veins. Weinstein, J.S., Grossman, W., Weintraub, R.M., Thurer, R.L., Johnson, R.G., Morgan, K.G. Circulation (1989) [Pubmed]
  16. Detection of intraluminal release of endothelium-derived relaxing factor from human saphenous veins. Chua, Y.L., Pearson, P.J., Evora, P.R., Schaff, H.V. Circulation (1993) [Pubmed]
  17. Relation of saphenous vein graft obstruction to serum cholesterol levels. Daida, H., Yokoi, H., Miyano, H., Mokuno, H., Satoh, H., Kottke, T.E., Hosoda, Y., Yamaguchi, H. J. Am. Coll. Cardiol. (1995) [Pubmed]
  18. Phosphatidylinositol 3-kinase and focal adhesion kinase are early signals in the growth factor-like responses to thrombospondin-1 seen in human vascular smooth muscle. Lymn, J.S., Rao, S.J., Clunn, G.F., Gallagher, K.L., O'Neil, C., Thompson, N.T., Hughes, A.D. Arterioscler. Thromb. Vasc. Biol. (1999) [Pubmed]
  19. Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis. George, S.J., Angelini, G.D., Capogrossi, M.C., Baker, A.H. Gene Ther. (2001) [Pubmed]
  20. 5-HT(1)-like receptor agonists and the pathophysiology of migraine. Saxena, P.R., Ferrari, M.D. Trends Pharmacol. Sci. (1989) [Pubmed]
  21. Endothelium-derived relaxing factor and protection against contractions induced by histamine and serotonin in the human internal mammary artery and in the saphenous vein. Yang, Z.H., Diederich, D., Schneider, K., Siebenmann, R., Stulz, P., von Segesser, L., Turina, M., Bühler, F.R., Lüscher, T.F. Circulation (1989) [Pubmed]
  22. Preserved vasodilatory response to nitroglycerin in saphenous vein bypass grafts. Berglund, H., Luo, H., Nishioka, T., Eigler, N.L., Kim, C.J., Tabak, S.W., Siegel, R.J. Circulation (1996) [Pubmed]
  23. Progesterone receptor expression in human saphenous veins. Perrot-Applanat, M., Cohen-Solal, K., Milgrom, E., Finet, M. Circulation (1995) [Pubmed]
  24. Different interactions of platelets with arterial and venous coronary bypass vessels. Yang, Z.H., Stulz, P., von Segesser, L., Bauer, E., Turina, M., Lüscher, T.F. Lancet (1991) [Pubmed]
  25. Ventricular arrhythmias in chronic stable angina pectoris with surgical or medical treatment. de Soyza, N., Murphy, M.L., Bissett, J.K., Kane, J.J., Doherty, J.E. Ann. Intern. Med. (1978) [Pubmed]
  26. Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall. Medalion, B., Merin, G., Aingorn, H., Miao, H.Q., Nagler, A., Elami, A., Ishai-Michaeli, R., Vlodavsky, I. Circulation (1997) [Pubmed]
  27. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). Sauty, A., Colvin, R.A., Wagner, L., Rochat, S., Spertini, F., Luster, A.D. J. Immunol. (2001) [Pubmed]
  28. TGF-beta and endothelial cells inhibit VCAM-1 expression on human vascular smooth muscle cells. Gamble, J.R., Bradley, S., Noack, L., Vadas, M.A. Arterioscler. Thromb. Vasc. Biol. (1995) [Pubmed]
  29. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein. Kranzhöfer, A., Baker, A.H., George, S.J., Newby, A.C. Arterioscler. Thromb. Vasc. Biol. (1999) [Pubmed]
  30. Induction of cyclooxygenase-2 in human saphenous vein and internal mammary artery. Bishop-Bailey, D., Pepper, J.R., Haddad, E.B., Newton, R., Larkin, S.W., Mitchell, J.A. Arterioscler. Thromb. Vasc. Biol. (1997) [Pubmed]
  31. Characterization of endothelin receptors in human varicose veins. Barber, D.A., Wang, X., Gloviczki, P., Miller, V.M. J. Vasc. Surg. (1997) [Pubmed]
  32. Arginine vasopressin enhances sympathetic constriction through the V1 vasopressin receptor in human saphenous vein. Medina, P., Acuña, A., Martínez-León, J.B., Otero, E., Vila, J.M., Aldasoro, M., Lluch, S. Circulation (1998) [Pubmed]
  33. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency. Sharma, G.V., Khuri, S.F., Josa, M., Folland, E.D., Parisi, A.F. Circulation (1983) [Pubmed]
  34. Inhibition of sympathetic neurotransmission in canine blood vessels by adenosine and adenine nucleotides. Verhaeghe, R.H., Vanhoutte, P.M., Shepherd, J.T. Circ. Res. (1977) [Pubmed]
  35. Effect of subintimal resection on initial outcome and restenosis for native coronary lesions and saphenous vein graft disease treated by directional coronary atherectomy. A report from the CAVEAT I and II investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. Holmes, D.R., Garratt, K.N., Isner, J.M., Kearney, M., Berdan, L.G., Schwartz, R.S., Califf, R.M., Topol, E.J. J. Am. Coll. Cardiol. (1996) [Pubmed]
  36. Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. MaassenVanDenBrink, A., van den Broek, R.W., de Vries, R., Bogers, A.J., Avezaat, C.J., Saxena, P.R. Neurology (2000) [Pubmed]
WikiGenes - Universities